TEGSEDI Trademark

Trademark Overview

On Thursday, September 14, 2017, a trademark application was filed for TEGSEDI with the United States Patent and Trademark Office. The USPTO has given the TEGSEDI trademark a serial number of 87608910. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 14, 2025. This trademark is owned by Ionis Pharmaceuticals, Inc.. The TEGSEDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin
tegsedi

General Information

Serial Number87608910
Word MarkTEGSEDI
Filing DateThursday, September 14, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 14, 2025
Registration Number5740635
Registration DateTuesday, April 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and human therapeutic preparations for treating and preventing amyloidosis, genetic diseases, disorders and conditions, and protein diseases, disorders and conditions; pharmaceutical preparations and human therapeutic preparations for treating neuropathy, neurological dysfunction, and damage to nerves, tissue, organs, intestinal tract, or bone marrow; pharmaceutical preparations and human therapeutic preparations, namely, injectable antisense drugs for reducing production of transthyretin

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 14, 2025
Primary Code005
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateTuesday, January 1, 2019

Trademark Owner History

Party NameAKCEA THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameIonis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010
Party NameIonis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010
Party NameIonis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Trademark Events

Event DateEvent Description
Monday, September 18, 2017NEW APPLICATION ENTERED
Wednesday, September 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 18, 2017ASSIGNED TO EXAMINER
Thursday, December 21, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, December 21, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, December 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 21, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, December 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 5, 2018ASSIGNED TO LIE
Wednesday, January 31, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 20, 2018PUBLISHED FOR OPPOSITION
Tuesday, February 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 8, 2018SOU TEAS EXTENSION RECEIVED
Monday, October 8, 2018SOU EXTENSION 1 FILED
Monday, October 8, 2018SOU EXTENSION 1 GRANTED
Wednesday, October 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 24, 2019TEAS STATEMENT OF USE RECEIVED
Sunday, March 24, 2019SOU TEAS EXTENSION RECEIVED
Thursday, March 28, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, March 24, 2019SOU EXTENSION 2 FILED
Thursday, March 28, 2019SOU EXTENSION 2 GRANTED
Sunday, March 24, 2019USE AMENDMENT FILED
Thursday, March 28, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 28, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 29, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, March 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, July 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 30, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 25, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 25, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 25, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 25, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 25, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 25, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, November 14, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

tegsedi preparations pharmaceutical therapeutic human conditions diseases disorders treating namely marrow